Literature DB >> 22269948

Is Leber hereditary optic neuropathy treatable? Encouraging results with idebenone in both prospective and retrospective trials and an illustrative case.

Esfandiar J Sabet-Peyman1, Khizer R Khaderi, Alfredo A Sadun.   

Abstract

A 31-year-old woman developed subacute bilateral visual loss over a 2-week period. Two months later, the diagnosis of Leber hereditary optic neuropathy (LHON) 11778/ND4 was established and the patient was treated with 900 mg of idebenone daily. Over the ensuing 9 months, visual acuity improved from 20/200 to 20/25 in each eye with near-total resolution in visual field abnormalities. Our case report is in agreement with 2 large published series of patients with LHON treated with idebenone, raising hope for treatment of this visually devastating mitochondrial disorder.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22269948     DOI: 10.1097/WNO.0b013e318241da45

Source DB:  PubMed          Journal:  J Neuroophthalmol        ISSN: 1070-8022            Impact factor:   3.042


  5 in total

1.  Structural impairment patterns in peripapillary retinal fiber layer and retinal ganglion cell layer in mitochondrial optic neuropathies.

Authors:  Da Teng; Chun-Xia Peng; Hai-Yan Qian; Li Li; Wei Wang; Jun-Qing Wang; Bing Chen; Huan-Fen Zhou; Shi-Hui Wei
Journal:  Int J Ophthalmol       Date:  2018-10-18       Impact factor: 1.779

2.  Idebenone: A Review in Leber's Hereditary Optic Neuropathy.

Authors:  Katherine A Lyseng-Williamson
Journal:  Drugs       Date:  2016-05       Impact factor: 9.546

3.  Idebenone protects against retinal damage and loss of vision in a mouse model of Leber's hereditary optic neuropathy.

Authors:  Fabrice D Heitz; Michael Erb; Corinne Anklin; Dimitri Robay; Vincent Pernet; Nuri Gueven
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

Review 4.  The optic nerve: a "mito-window" on mitochondrial neurodegeneration.

Authors:  Alessandra Maresca; Chiara la Morgia; Leonardo Caporali; Maria Lucia Valentino; Valerio Carelli
Journal:  Mol Cell Neurosci       Date:  2012-08-15       Impact factor: 4.314

5.  Persistence of the treatment effect of idebenone in Leber's hereditary optic neuropathy.

Authors:  T Klopstock; G Metz; P Yu-Wai-Man; B Büchner; C Gallenmüller; M Bailie; N Nwali; P G Griffiths; B von Livonius; L Reznicek; J Rouleau; N Coppard; T Meier; P F Chinnery
Journal:  Brain       Date:  2013-02-06       Impact factor: 13.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.